Daniel Sundheim D1 Capital Partners
Daniel Sundheim is the founder of D1 Capital Partners, a firm active in public equities and private investments with a growth-oriented focus. He previously was a senior investor at Viking Global before launching D1. The firm’s public portfolio is tracked for exposure to consumer, technology, and other high-quality growth businesses.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$230M |
| 2 |
Pfizer
PFE
|
+$217M |
| 3 |
Live Nation Entertainment
LYV
|
+$189M |
| 4 |
Constellation Brands
STZ
|
+$166M |
| 5 |
VMRK
Vivmark Residential
VMRK
|
+$152M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SGI
Somnigroup International
SGI
|
+$280M |
| 2 |
GE Aerospace
GE
|
+$239M |
| 3 |
Nu Holdings
NU
|
+$211M |
| 4 |
Meta Platforms (Facebook)
META
|
+$207M |
| 5 |
Microsoft
MSFT
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 24.5% |
| 2 | Communication Services | 19.53% |
| 3 | Healthcare | 14.94% |
| 4 | Consumer Staples | 12.81% |
| 5 | Real Estate | 11.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SGI
26
Somnigroup International
SGI
$13.6B
| $73.6M | 1.12% |
1,296,172
-5,381,300
| -81% | -$280M |
|
27
Procore
PCOR
$9.65B
| $66.8M | 1.02% |
812,659
| – | – |
|
28
Rivian
RIVN
$24.6B
| $64.2M | 0.98% |
5,866,314
| – | – |
|
29
Analog Devices
ADI
$182B
| $59.1M | 0.9% |
+299,000
| New | +$57.5M |
|
30
Workday
WDAY
$49.4B
| $56.1M | 0.85% |
+205,500
| New | +$58.5M |
|
31
dLocal
DLO
$4.46B
| $55.4M | 0.84% |
3,765,649
+1,029,000
| +38% | +$17.2M |
|
32
Lexeo Therapeutics
LXEO
$400M
| $39.3M | 0.6% |
2,506,607
| – | – |
|
33
Guidewire Software
GWRE
$15.8B
| $36.6M | 0.56% |
+313,733
| New | +$35.9M |
|
34
Camden Property Trust
CPT
$10.8B
| $32.2M | 0.49% |
327,352
-1,149,575
| -78% | -$111M |
|
35
Entegris
ENTG
$22B
| – | – |
-544,178
| Closed | -$65.2M |
|
|
36
GE Aerospace
GE
$361B
| – | – |
-2,346,433
| Closed | -$239M |
|
37
Mastercard
MA
$509B
| – | – |
-208,305
| Closed | -$88.8M |
|
38
RH
RH
$2.9B
| – | – |
-326,000
| Closed | -$95M |
|
39
TKO Group
TKO
$14.1B
| – | – |
-523,587
| Closed | -$42.7M |
|
40
Visa
V
$693B
| – | – |
-305,478
| Closed | -$79.5M |
|
Similar funds
Daniel Sundheim's Q1 2024 Portfolio in Review
As of Q1 2024, Daniel Sundheim held 40 positions worth $6.58B, up 16% from $5.69B the previous quarter. Its ten largest holdings account for 64% of the portfolio.
Daniel Sundheim deployed $205M of net new capital in Q1 2024, opening 12 new positions and adding to 9 existing holdings. Its largest new stake was Pfizer: 7,830,000 shares worth $217M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 25% of assets, down from 25% a quarter earlier, followed by Communication Services and Healthcare.
On the sell side, the largest reduction was Somnigroup International, an estimated $280M trimmed.
- Daniel Sundheim's largest Q1 2024 buy was Pfizer: 7,830,000 shares worth $217M.
- Daniel Sundheim added most to Philip Morris in Q1 2024, an estimated $230M increase.
- Daniel Sundheim's biggest Q1 2024 reduction was Somnigroup International, cutting an estimated $280M.
- Daniel Sundheim fully exited GE Aerospace in Q1 2024, selling an estimated $239M.
- Daniel Sundheim's ten largest holdings make up 64% of its $6.58B portfolio in Q1 2024.
- Daniel Sundheim opened 12 new positions and closed 6 in Q1 2024.
- Daniel Sundheim's portfolio value rose 16% quarter-over-quarter to $6.58B.
Based on D1 Capital Partners's 13F filing for Q1 2024, filed 15 May 2024.